Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture
Multiple community reports describe improvements by day 2 or 3 that seem almost too fast to be real
By promoting angiogenesis (new blood vessel formation), enhancing fibroblast activity, stimulating collagen synthesis, and modulating inflammation rather than simply suppressing it, specific peptides target the root biological limitations that make shoulder healing so difficult
Increasing the number of pharmacological/therapeutic targets of the anti-ulcer, cytoprotective stable gastric pentadecapeptide BPC 157
10.1146/annurev.pharmtox.43.050802.112309 388
US$ 26.59
US$ 24.93
US$ 26.45